Home : DrugWatch : Emend : News Articles

Emend - News Articles

MSD - Nytt läkemedel: IVEMEND förebygger illamående och kräkning av... - MyNewsdesk


Introduktionen av EMEND (aprepitant) kapslar innebar att man kunde påverka hjärnans signaler direkt till kräkcentrum. IVEMEND (fosaprepitant) 150 mg är en ...
Vail Daily columnist Jack Van Ens: Jefferson envisioned living Constitution | VailDaily.com


Jesus treated sacred laws as living documents, which evolving insights and social pressures might emend. Shakespeare, also, spun new scenarios from old scripts. His plays borrow from the past. He revised plots and characters from vintage sources-like Plutarch and Holinshed. Shakespeare ...
Oncology buy-and-bill evolving - - Drug Topics


Aprepitant (Emend, Merck) is used for nausea and vomiting associated with chemotherapy. But it can be reimbursed only with dexamethasone and only when the patient has had methotrexate administered in a physician office. All 3 agents have to be billed on the same ...
El SAS busca atajos contra el cáncer - abcdesevilla.es


Según explica ahora la titular del ramo, aunque la Agencia Española del Medicamento aprobó en 2005 la realización de un ensayo clínico con el aprepitant para el tratamiento de pacientes con cáncer, cuyos promotores eran los doctores Muñoz Sáez y Soult Rubio, y a ...
Netherlands Corporate News - EU verstrekt goedkeuring voor ivemend 150 mg in één dosis van MSD


EMEND ® is een gedeponeerd handelsmerk van Merck Sharp & Dohme Corp., een dochterbedrijf van Merck & Co., Inc. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke ...
L'Unione Europea approva la nuova dose singola di MDS, 'Ivemend'® (fosaprepitant) 150 mg per la prevenzione di nausea e vomito indotti dalla chemioterapia - ANSA.it


EMEND ® è un marchio registrato di Merck Sharp & Dohme Corp., consociata di Merck & Co., Inc. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e ...
La Unión Europea aprueba el nuevo fármaco de única dosis 'Ivemend' fosaprepitant de 150 mg de MSD para la prevención de las náuseas y los vómitos provocados por la quimioterapia


EMEND ® es una marca comercial registrada de Merck Sharp & Dohme Corp., una filial de Merck & Co., Inc. "El comunicado en el idioma original, es la versión oficial y autorizada del mismo. La traducción es solamente un medio de ayuda y deberá ser comparada con el ...
The IN VIVO Blog: Amid A Lot of Snarky, Back-RoomTalk, Some Deals Got Done


to in-license products to establish an oncology presence and has since in-licensed nine cancer-related compounds, including Merck's antiemetic Emend. ...
Merck Sharpe and Dohme receives EU approval for new Ivemend regimen


It is designed to be more convenient than the previous 115mg fosaprepitant regime, which needed to be supplemented with Emend capsules taken on days two and three. Dr Steven Grunberg, professor of medicine and pharmacology at the University of Vermont, said this will provide a ...
Want to contact a Washington, DC Emend lawyer? ...Get a free case evaluation from one of our Washington, DC Emend lawyers now.

Need An Emend Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a Washington, DC Emend lawyer? ...Get a free case evaluation from one of our Washington, DC Emend lawyers now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Emend Case - Submit Your Information Below

Do you need legal assistance with your Emend case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Emend Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.